Craft
  • Home
  •  / Tarveda Therapeutics
Tarveda Therapeutics

Tarveda Therapeutics

Total Funding

$158.6 M

Tarveda Therapeutics Summary

Company summary

Overview
Tarveda Therapeutics develops novel cancer therapies created to treat solid tumors. It creates miniaturized drug conjugates for patients with neuroendocrine cancers enabling effective penetration into solid tumors to cause cancer cell death.
Type
Private
Founded
2011
HQ
Watertown, MA, US | view all locations
Website
http://www.tarvedatx.com/
Cybersecurity rating
Sectors

Key people

  • Brian Roberts

    Brian Roberts, President, CEO, Director

  • Dennis Ausiello, Director

    • Karen Hong, Director

      LocationsView all

      1 location detected

      • Watertown, MA HQ

        United States

        134 Coolidge Ave

      Footer menu